Chronic Grape Extract in Crosstraining Athletes: A Randomized Crossover Trial
CROSSUVA
Effect of Chronic Grape Extract Supplementation in Trained Cross-training Athletes: A Randomized, Triple-blinded, Placebo-Controlled Crossover Study
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of this study is to investigate the effect of cronic GSE intake in crosstraining may have a favorable impact on biochemical markers, recovery, and performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2025
CompletedFirst Posted
Study publicly available on registry
August 6, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedAugust 6, 2025
July 1, 2025
4 months
July 21, 2025
July 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Performance
Performance measured through the countermovement jump
48 hours
Performance
Deep squat test at 70% of repetition maximum
60 minutes
Secondary Outcomes (11)
Attention
60 minutes
Performance: Weight used in the crosstraining session
60 minutes
Performance: Time performed in the crosstraining session
60 minutes
Subjective fatigue throug the the RPE scale
60 minutes
Gastrointestinal distress
60 minutes
- +6 more secondary outcomes
Study Arms (2)
Grape seed extract
EXPERIMENTAL600 mg of Grape seed extract
Placebo
PLACEBO COMPARATORPreparation of colorants, sweeteners, aromas, and acidulants
Interventions
Eligibility Criteria
You may qualify if:
- Age: 18-35 years.
- Body mass index: 18.5-30 kg/m2.
- Ability to understand the instructions, objectives, and study protocol.
- Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
- Resident on the island of Tenerife.
You may not qualify if:
- History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
- Any chronic pathology in which the intake of nutritional supplements, especially use of antioxidant supplements during the 4 weeks prior to the start of the study.
- Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
- Use of medications that may affect the study results.
- Unstable body weight for 3 months prior to the start of the study (\> 4 kg loss or gain in weight).
- Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse.
- On a special diet or prescribed for other reasons (e.g., celiac disease).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de la Laguna
Santa Cruz de Tenerife, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
July 21, 2025
First Posted
August 6, 2025
Study Start
September 1, 2025
Primary Completion
December 20, 2025
Study Completion
January 31, 2026
Last Updated
August 6, 2025
Record last verified: 2025-07